The Use of Antioxidants as Potential Co-Adjuvants to Treat Chronic Chagas Disease

Chagas disease is a neglected tropical disease caused by the flagellated protozoa <i>Trypanosome cruzi</i>. This illness affects to almost 8-12 million people worldwide, however, is endemic to Latin American countries. It is mainly vectorially transmitted by insects of the Triatominae fa...

Full description

Saved in:
Bibliographic Details
Main Authors: Edio Maldonado (Author), Diego A. Rojas (Author), Fabiola Urbina (Author), Aldo Solari (Author)
Format: Book
Published: MDPI AG, 2021-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_cfde0ff8f4d24f1bbce1fa60b76b462b
042 |a dc 
100 1 0 |a Edio Maldonado  |e author 
700 1 0 |a Diego A. Rojas  |e author 
700 1 0 |a Fabiola Urbina  |e author 
700 1 0 |a Aldo Solari  |e author 
245 0 0 |a The Use of Antioxidants as Potential Co-Adjuvants to Treat Chronic Chagas Disease 
260 |b MDPI AG,   |c 2021-06-01T00:00:00Z. 
500 |a 10.3390/antiox10071022 
500 |a 2076-3921 
520 |a Chagas disease is a neglected tropical disease caused by the flagellated protozoa <i>Trypanosome cruzi</i>. This illness affects to almost 8-12 million people worldwide, however, is endemic to Latin American countries. It is mainly vectorially transmitted by insects of the Triatominae family, although other transmission routes also exist. <i>T. cruzi</i>-infected cardiomyocytes at the chronic stage of the disease display severe mitochondrial dysfunction and high ROS production, leading to chronic myocardial inflammation and heart failure. Under cellular stress, cells usually can launch mitochondrial biogenesis in order to restore energy loss. Key players to begin mitochondrial biogenesis are the PGC-1 (PPARγ coactivator 1) family of transcriptional coactivators, which are activated in response to several stimuli, either by deacetylation or dephosphorylation, and in turn can serve as coactivators for the NRF (nuclear respiratory factor) family of transcription factors. The NRF family of transcriptional activators, namely NRF1 and NRF2, can activate gene expression of oxidative phosphorylation (OXPHOS) components, mitochondrial transcriptional factor (Tfam) and nuclear encoded mitochondrial proteins, leading to mitochondrial biogenesis. On the other hand, NRF2 can activate gene expression of antioxidant enzymes in response to antioxidants, oxidants, electrophile compounds, pharmaceutical and dietary compounds in a mechanism dependent on KEAP1 (Kelch-like ECH-associated protein 1). Since a definitive cure to treat Chagas disease has not been found yet; the use of antioxidants a co-adjuvant therapy has been proposed in an effort to improve mitochondrial functions, biogenesis, and the antioxidant defenses response. Those antioxidants could activate different pathways to begin mitochondrial biogenesis and/or cytoprotective antioxidant defenses. In this review we discuss the main mechanisms of mitochondrial biogenesis and the NRF2-KEAP1 activation pathway. We also reviewed the antioxidants used as co-adjuvant therapy to treat experimental Chagas disease and their action mechanisms and finish with the discussion of antioxidant therapy used in Chagas disease patients. 
546 |a EN 
690 |a <i>Trypanosoma cruzi</i> 
690 |a ROS 
690 |a Chagas 
690 |a antioxidants 
690 |a oxidative stress 
690 |a mitochondrial biogenesis 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antioxidants, Vol 10, Iss 7, p 1022 (2021) 
787 0 |n https://www.mdpi.com/2076-3921/10/7/1022 
787 0 |n https://doaj.org/toc/2076-3921 
856 4 1 |u https://doaj.org/article/cfde0ff8f4d24f1bbce1fa60b76b462b  |z Connect to this object online.